Literature DB >> 8892076

Multiple sclerosis: from a myelin point of view.

G L Boccaccio1, L Steinman.   

Abstract

Multiple sclerosis (MS) is a demyelinating disease during which an autoimmune reaction is directed against oligodendrocytes. Alterations of normal myelin structure or oligodendrocyte metabolism may be primary events that influence the susceptibility to MS. Once triggered, the immune system attacks and destroys myelin and the myelin forming cell. Evidence is presented that the oligodendrocyte responds to the attack by immune cells and their secreted products through modulation of its metabolism and gene expression. Cytokines, immunoglobulins, and complement complexes may elicit a survival response in the oligodendrocytes, involving the induction of heat shock proteins and other protective molecules. The possibility of manipulating these complex glial cell functions and controlling their pathologic interactions with immune cells will illuminate how myelin damage can be contained and how the injured tissue can be repaired.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892076     DOI: 10.1002/(SICI)1097-4547(19960915)45:6<647::AID-JNR1>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  4 in total

1.  Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients.

Authors:  Brian Niland; Gabriella Miklossy; Katalin Banki; William E Biddison; Livia Casciola-Rosen; Antony Rosen; Denis Martinvalet; Judy Lieberman; Andras Perl
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

2.  Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2007-03-08       Impact factor: 4.147

3.  Serum and Saliva Myelin Basic Protein as Multiple Sclerosis Biomarker.

Authors:  Mohammad Hossein Mirzaii-Dizgah; Mohammad Reza Mirzaii-Dizgah; Iraj Mirzaii-Dizgah
Journal:  Basic Clin Neurosci       Date:  2021-05-01

4.  Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice.

Authors:  Magdalena Polanczyk; Srikanth Yellayi; Alex Zamora; Sandhya Subramanian; Micah Tovey; Arthur A Vandenbark; Halina Offner; James F Zachary; Parley D Fillmore; Elizabeth P Blankenhorn; Jan-Ake Gustafsson; Cory Teuscher
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.